Pharmacists and precision oncology
7 Aug 2018
Pharmacists and precision oncology
Involving pharmacists in oral oncology treatments
Two important pancreatic studies: PRODIGE 24 and PREOPANC
Rare mutations in non small cell lung cancer
The promise of immunotherapy in head and neck, and prostate cancer
Several important studies for lung cancer
The PERSEPHONE trial: 6 months and 12 months of trastuzumab in breast cancer
Key advances in ALL and AML
Four studies about relapsed myeloma and advanced disease
Apps and mobile games for the cancer community
Stephan Kiefer outlines the iManageCancer platform
iManageCancer clinical pilot design and preliminary outcomes